Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 17, Issue 1, 2011, Pages 14-17

  Cansu, Barş ^a   Cansu, Döndü U ^a   Kaşifoǧlu, Timuçin ^a   Gülbas, Zafer ^a   Korkmaz, Cengiz ^a  

^a Eskizehir Osmangazi University   (Turkey)

Author keywords

acute phase response reactants; Adiponectin; disease activity; rheumatoid arthritis

Indexed keywords

ADIPONECTIN; CHOLESTEROL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ACUTE PHASE RESPONSE; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADIPONECTIN; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; CHOLESTEROL, HDL; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78651367541     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318204a587     Document Type: Article

References (16)

1. Lara-Castro C, Fu Y, Chung BH, et al. Adiponectin and the metabolic syndrome: mechanism mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007;18:263-270.
2. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk ofmyocardial infarction in men. J AmA. 2004;291: 1730-1737.
3. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum. 2005;52:722-732.
4. van Halm VP, Nurmohamed MT, Twisk JW, et al. Disease-modifying antirheumatic drugs are associated with reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther. 2006;8:R151.
5. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65: 1198-1201.
6. Schaffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. JAMA. 2003;290:1709-1710.
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
8. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification andreporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039-1049.
9. Senolt L, Pavelka K, Housa D, et al. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine. 2006;35:247-252.
10. Härle P, Sarzi-Puttini P, Cutolo M, et al. No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:970-971.
11. Komai N, Morita Y, Sakuta T, et al. Antitumor necrosis factor therapy increases serum adiponectin levels with the improvement ofendothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol. 2007;17:385-390.
12. Nishida K, Okada Y, Nawata M, et al. Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocrine Journal. 2008;55:213-216.
13. Serelis J, Kontagianni MD, Katsiougiannis S, et al. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol. 2008;27:795-797.
14. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8: 731-737.
15. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum. 2006;54: 2765-2775.
16. Svenson KL, Pollare T, Lithell H, et al. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988;37:125-130.